China Shineway Pharmaceutical Group Limited (FRA:C1S)
Germany flag Germany · Delayed Price · Currency is EUR
0.9300
-0.0200 (-2.11%)
At close: Sep 9, 2025

FRA:C1S Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Cash & Equivalents
6,8616,1405,8895,0264,2063,943
Upgrade
Short-Term Investments
-4.484.023.694.325.32
Upgrade
Trading Asset Securities
100.42350.022020.23--
Upgrade
Cash & Short-Term Investments
6,9616,4955,9135,0504,2103,948
Upgrade
Cash Growth
11.65%9.84%17.08%19.96%6.63%-0.52%
Upgrade
Accounts Receivable
1,1921,2021,260975.06825.18760.66
Upgrade
Other Receivables
-66.8163.9267.4840.8723.07
Upgrade
Receivables
1,1921,2691,3241,043866.05783.73
Upgrade
Inventory
722.37813.19897.71657.66587.96443
Upgrade
Other Current Assets
77.22219.9432.0135.06343.99
Upgrade
Total Current Assets
8,9538,5998,1556,7825,6995,519
Upgrade
Property, Plant & Equipment
1,2251,2191,2051,2171,2521,395
Upgrade
Goodwill
165.96165.96165.96165.96165.96102.5
Upgrade
Other Intangible Assets
18.9123.3232.7947.3566.4336.96
Upgrade
Long-Term Deferred Tax Assets
24.7334.3315.2319.2220.4723.1
Upgrade
Other Long-Term Assets
-----137.14
Upgrade
Total Assets
10,38810,0429,5748,2327,2047,214
Upgrade
Accounts Payable
377.68402.96484.79308.75228.62164.38
Upgrade
Accrued Expenses
-1,1991,121856.76483.21319.13
Upgrade
Short-Term Debt
300330300--369.32
Upgrade
Current Portion of Leases
8.518.270.976.537.597.79
Upgrade
Current Income Taxes Payable
68.8984.27105.91107.7965.158.37
Upgrade
Current Unearned Revenue
103.31101.75127.4165.22117.0578.42
Upgrade
Other Current Liabilities
1,570323.67294.13220.54196.81197.28
Upgrade
Total Current Liabilities
2,4282,4502,4341,6661,0981,195
Upgrade
Long-Term Leases
4.358.260.360.917.3215.03
Upgrade
Long-Term Unearned Revenue
105.5781.8588.89163.99171.59204.31
Upgrade
Long-Term Deferred Tax Liabilities
11.5634.5216.2618.8425.195.3
Upgrade
Total Liabilities
2,5782,5752,5391,8491,3021,419
Upgrade
Common Stock
87.6687.6687.6687.6687.6687.66
Upgrade
Additional Paid-In Capital
-422.14422.14422.14422.14422.14
Upgrade
Retained Earnings
-7,4527,0206,3685,8795,778
Upgrade
Comprehensive Income & Other
7,722-494.89-494.89-494.89-487.32-493.42
Upgrade
Total Common Equity
7,8107,4677,0356,3835,9015,794
Upgrade
Shareholders' Equity
7,8107,4677,0356,3835,9015,794
Upgrade
Total Liabilities & Equity
10,38810,0429,5748,2327,2047,214
Upgrade
Total Debt
341.34346.53301.337.4414.91392.14
Upgrade
Net Cash (Debt)
6,6206,1485,6115,0434,1953,556
Upgrade
Net Cash Growth
12.51%9.56%11.28%20.21%17.97%-0.23%
Upgrade
Net Cash Per Share
8.768.147.436.685.564.70
Upgrade
Filing Date Shares Outstanding
755.4755.4755.4755.4755.4754.6
Upgrade
Total Common Shares Outstanding
755.4755.4755.4755.4755.4754.6
Upgrade
Working Capital
6,5256,1495,7215,1174,6014,324
Upgrade
Book Value Per Share
10.349.889.318.457.817.68
Upgrade
Tangible Book Value
7,6257,2786,8366,1695,6695,655
Upgrade
Tangible Book Value Per Share
10.099.639.058.177.507.49
Upgrade
Machinery
-1,4941,4891,4381,3921,388
Upgrade
Construction In Progress
-195.51117.68193.06130.17115.5
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.